- Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Stone, G.W., Moliterno, D.J., Bertrand, M., Neumann, F.J., Herrmann, H.C., Powers, E.R., Grines, C.L., Moses, J.W., Cohen, D.J., Cohen, E.A., Cohen, M., Wolski, K., DiBattiste, P.M., Topol, E.J. Circulation (2002)